Emgality ® ▼ (galcanezumab)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Emgality Summary of Product Characteristics (SmPC)

Emgality®▼ (galcenezumab) device: Disposal

The pen or syringe should be disposed in a sharps disposal container.

Additional information

After the medicine has been injected, the base cap of the pen or the needle cap of the syringe should not be placed back onto the device. They can be thrown away in the bin.1

The pen or syringe should be disposed in a sharps disposal container. Patients should follow the instructions of their doctor, pharmacist or nurse for device disposal.1

Used or unused pens or syringes or sharps container should not be recycled.1,2

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.3


1. Emgality [instructions for use]. Eli Lilly Nederland B.V., The Netherlands.

2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

3. Emgality [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: February 15, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request